Jerrold B. Grossman - 26 Feb 2024 Form 4 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Role
Director
Signature
/s/ Dr. Jerrold B. Grossman, by Brian Lenz as Attorney-in-fact
Issuer symbol
ADMA
Transactions as of
26 Feb 2024
Net transactions value
$0
Form type
4
Filing time
28 Feb 2024, 21:00:46 UTC
Previous filing
30 Aug 2023
Next filing
30 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADMA Common Stock Award $0 +24,040 +5.4% $0.000000 467,305 26 Feb 2024 Direct F1, F2
holding ADMA Common Stock 22,857 26 Feb 2024 See Footnote F3
holding ADMA Common Stock 31,381 26 Feb 2024 See Footnote F4
holding ADMA Common Stock 38,294 26 Feb 2024 See Footnote F5
holding ADMA Common Stock 175 26 Feb 2024 See Footnote F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADMA Stock Option (right to buy) Award $0 +37,541 $0.000000 37,541 26 Feb 2024 Common Stock 37,541 $5.40 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date.
F2 Includes, as of the transaction date, (i) 24,040 RSUs granted on February 26, 2024 and reported on this Form 4, subject to vesting as set forth in footnote (1); (ii) 25,815 RSUs granted on March 6, 2023, which will vest in full on March 6, 2024; and (iii) 417,450 shares of common stock owned by the reporting person.
F3 These shares are owned by Brookwood LLC ("Brookwood"). The reporting person is the managing member of Brookwood.
F4 These shares are owned by the Jerrold Grossman 2019 Irrevocable Trust, of which Dr. Grossman serves as investment trustee.
F5 These shares are owned by Genesis Foundation Inc. ("Genesis"). The reporting person is the President of Genesis.
F6 These shares are owned by the reporting person's wife.
F7 The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.